Research suggests that topical curcumin, the active compound in turmeric, shows promise as an anti-inflammatory agent, particularly when delivered in formulations designed to improve skin penetration, such as elastic vesicle-based ointments that performed comparably to a standard NSAID in animal models. Studies in humans have focused primarily on oral mucosal conditions like oral lichen planus, where curcumin gels and lozenges demonstrated meaningful reductions in pain and lesion severity, though corticosteroid treatments generally outperformed curcumin when directly compared. The available evidence includes animal and formulation studies, small pilot trials, and a broad herbal medicine review, and most human studies are limited by small sample sizes and short durations, making it difficult to draw firm conclusions. Overall, the research is moderately supportive but mixed in direction, and authors across these studies consistently call for larger, more rigorous trials before curcumin-based topical preparations can be recommended as standalone anti-inflammatory treatments.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Development and evaluation of curcumin-loaded elastic vesicles as an effectiv... | Other | 2015 | Supports | 100 |
| Comparison of the Effectiveness Differences between Western and Chinese Medic... | Review | 2025 | Mixed | 95 |
| Evaluation of Efficacy of 1% Curcuminoids as Local Application in Management ... | Other | 2017 | Mixed | 90 |
| Evaluation of Triamcinolone Acetonide and Curcumin Lozenges in Patients With ... | Other | 2025 | Supports | 85 |